Cell surface protein associated with human chronic lymphocytic leukemia

Details for Australian Patent Application No. 2004247069 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Mc Whirter, John

Agent Shelston IP

Pub. Number AU-A-2004247069

PCT Pub. Number WO2004/110369

Priority 60/475,156 02.06.03 US; 60/530,094 15.12.03 US

Filing date 2 June 2004

Wipo publication date 23 December 2004

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/110369 Priority application(s): WO2004/110369

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247071-Method for the treatment of malignancies

2004247068-Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes